Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure

Pedro Caravaca Perez1,2, José R González-Juanatey1,3, Jorge Nuche1,4

  • 1CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Insights

Galectin-3 (Gal-3) predicts mortality in acute heart failure (AHF) patients, but its prognostic value is significant only in those with renal dysfunction. Renal function impacts Gal-3 interpretation in AHF.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarker Research

Background:

  • Galectin-3 (Gal-3) is an inflammatory marker linked to heart failure (HF) progression.
  • The interplay between Gal-3 and renal function in acute HF (AHF) requires further investigation.

Purpose of the Study:

  • To assess the prognostic relationship between renal function and Gal-3 levels in patients hospitalized for AHF.
  • To determine if renal function modifies the predictive value of Gal-3 for mortality.

Main Methods:

  • An observational, prospective, multicenter registry of 1,201 AHF patients.
  • Patients were stratified by estimated glomerular filtration rate (eGFR) into preserved (≥60 mL/min/1.73 m²) and impaired (<60 mL/min/1.73 m²) renal function groups.
  • Cox regression analysis evaluated Gal-3 association with 12-month mortality, adjusting for eGFR and other variables.

Main Results:

  • Gal-3 levels negatively correlated with eGFR (rho = -0.51, p < 0.001).
  • Elevated Gal-3 was associated with higher 12-month mortality in multivariate analysis (HR = 1.010, p = 0.038).
  • Prognostic value of Gal-3 was significant in patients with renal dysfunction (HR = 1.010, p = 0.033) but not in those with preserved renal function (HR = 0.990, p = 0.472).

Conclusions:

  • Galectin-3 is a marker of increased mortality in AHF patients with renal dysfunction.
  • Renal function significantly influences the prognostic utility of Gal-3 in AHF.
  • eGFR adjustment is crucial for accurate interpretation of Gal-3 levels in AHF.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
173
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
515
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
536
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
119
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
67
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
111